▶ Full Post Text
I spent the morning of July 14, 2026 reading the pricing release for what is now the largest Chinese semiconductor listing ever. The company priced at 8.66 yuan per share, roughly 308.9 times trailing earnings. The base deal is 6.688 billion shares raising 57.9 billion yuan, about $8.5 billion at the 6.77 exchange rate that morning. With the 15% greenshoe exercised fully, that becomes 7.688 billion shares and up to 66.6 billion yuan, around $9.8 billion. That is about 2.3 times the original plan of roughly 29.5 billion yuan, or about $4.3 billion.
The timeline moved fast. Book building opened July 13. Pricing came July 14. The offering announcement hit July 15. Online and offline subscription ran July 16, and the same day allotment announcement put the online tranche at roughly 244 times subscribed with about 9.4 million accounts applying. The listing is set for July 27 on the Star Market.
This is a memory company, the world's fourth largest DRAM maker by most estimates, with its share of global supply quoted anywhere from about 4% to about 8% depending on the quarter you check. Memory is cyclical, commodity, brutally capital intensive. The 308 multiple is not pricing a DRAM cycle. It is pricing something else entirely.
The thing that actually got me was the week immediately before book building opened. On July 9, the onshore semiconductor index rose 9.66% in a single session. The Star 50 index rose 8.41%. One major chip design name hit its 10% daily limit, ending a seven session slide. On July 10, the Star 50 gave back 5.53%. That same chip design name fell 7.76%. Up 8% then down 5% like it never happened. Insane.
Then the deal priced. Institutions let the raise get upsized 2.3 times and still cleared it at 308 times earnings. I cannot believe this cleared. The marginal buyer is underwriting memory self sufficiency, not the memory cycle. That is a useful signal of where domestic capital allocation is heading, and a dangerous one. 308x leaves no room for the cycle turning, and the tape just demonstrated how fast sentiment can reverse.
There is an unresolved export control overhang. The company sits on a U.S. defense list, and per reporting from mid June 2026, an interagency recommendation to add it to the commerce entity list was paused that month. So the risk is live but not crystallized.
I have no access to this deal. I cannot buy the A share directly from my U.S. account. I looked at the US listed fund that tracks the Star Market, but that is a broad basket of 50 names that will not hold this stock at debut, so it buys me the sector, not the deal. I am watching it as a signal, not a position.
For July 27 I am watching whether this thing holds its offer price into August. The whiplash is already replaying. The Star 50 fell another 4.3% on July 15 and Shanghai closed July 16 at its lowest level in more than three months, with chips leading the selling while the subscription window was open. If the debut lands in that kind of tape, the durability of this valuation gets tested immediately.
I looked at how the wrappers I already own would ever pick this up. KWEB is zero A shares and internet only, so it structurally never would. CNQQ tracks the Solactive ChinaAMC Transformative China Tech USD Index TR, about 100 names across A shares and Hong Kong listings with a semi annual rebalance and a 10% single stock weight cap, so a mechanical entry path at least exists once a new name clears the index's size and liquidity gates. That is still a small fund launched September 2025 with AUM around $16.5 million, so liquidity is a real question mark, and I am not claiming CXMT will be added. I am just noting the mechanics.